Society of Cannabis Clinicians

Quarterly Meeting: Featuring Douglas Bruce, PhD, MSW on Cannabis & HIV
2023-05-26 09:00 - 10:00 (America/Los_Angeles)
Join us for a special Quarterly Meeting featuring Dr. Douglas Bruce on the topic of: The spectrum of cannabis use among young persons living with HIV/AIDS.
Douglas Bruce, PhD, MSW is a public health researcher and earned his PhD in public health from the University of Illinois at Chicago. His mixed methods research focuses on the health behavior of persons living with chronic conditions, including the secondary prevention needs of young persons living with HIV/AIDS, and the role of cannabis in the lives of persons living with chronic disease. He has served as principal investigator on grants from the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Child Health and Human Development. As a program evaluation and development consultant, Dr. Bruce has worked with a number of local organizations, such as the AIDS Foundation of Chicago and Chicago Department of Public Health, as well as national and international organizations, including the Centers for Disease Control and Prevention and the US Agency for International Development.
Register

CannMed Medical Practicum
2023-05-15 08:00 - 10:00 (America/Los_Angeles) | Marco Island, FL, Marco Island, FL, United States
This workshop is for clinicians exploring the therapeutic potential of medicinal plants, or laypersons looking to understand these medicines at a clinical level. It begins with an exploration of the human endocannabinoid system, and takes a deep dive into how these plants work to alleviate a host of conditions, including dosing, safety, efficacy, side effects, and more. Full day with CME and CEU credits available. We are proud to announce that all of the practicum speakers are long-time members of the SCC.
Register

Book Launch with Peter Grinspoon, MD -- Seeing through the Smoke: A Cannabis Specialist Untangles the Truth about Marijuana
2023-05-10 09:00 - 10:00 (America/Los_Angeles)
This edition of the SCC / Csequence Journal Club will feature Peter Grinspoon, MD as he discusses his new book (available on April 20, 2023).
You can pre-order the book here.
Description:
Depending on which doctor you speak with, or which websites you read, cannabis could be an appealing, low-risk medicine – even an aid to wellness – or an insidiously addictive drug rotting the brains of our youth. This dissonance confuses young people, distressed patients, and paralyzes politicians, all while inviting dubious sources of information and resulting in uninformed choices, enhanced polarization, and a fragmented national policy.
Seeing Through the Smoke is an unflinching examination at the grossly misunderstood drug that uses data-driven medical science and a critical historical perspective to reveal the truth behind cannabis. In this balanced and measured investigation, Cannabis specialist and Instructor in Medicine at Harvard Medical School Dr. Peter Grinspoon untangles the reality behind cannabis, revealing how we ended up with radically divergent understandings of the drug and pointing a way toward a middle ground that we can all share.
Moving through an illuminating tour of the social history and the medical science behind cannabis, Grinspoon unpacks the layers of disinformation left by a sordid history of government propaganda, racial suppression, and indifference from the medical community to answer questions like:

Is cannabis addictive?
What are its best-established medical uses?
Can cannabis help cure cancer?
How does cannabis affect memory?
How dangerous is cannabis for teens?
Is cannabis a safer treatment for ADHD and PTSD?
What exactly is CBD and how is it different from marijuana?
What are the most concerning side effects?

By focusing on the most critical purported harms—driving, pregnancy, addictiveness, memory—and by focusing on the most commonly cited medical benefits—relieving chronic pain, sleep, anxiety, PTSD, autism, and cancer—Seeing Through the Smoke will help patients, parents, doctors, health experts, regulators, and politicians move beyond biased perceptions and arrive at a shared reality towards cannabis.
Register

Special Presentation: Fred Gardner & Dr. Jeffrey Hergenrather on the History of SCC
2023-04-28 09:00 - 10:00 (America/Los_Angeles)
Join us for this Special Presentation with Fred Gardner and Dr. Jeffrey Hergenrather as they recount pivotal moments in California’s medical cannabis movement — Proposition 215, Dr. Tod Mikuriya, and the formation of the California Cannabis Research Medical Group (CCRMG) / Society of Cannabis Clinicians.
Register

Roundtable Discussion on the New Certification in Basic Cannabinoid Medicine
2023-04-20 09:00 - 10:00 (America/Los_Angeles)
Register

SCC and Csequence Journal Club Presents: Adam Abodeely, MD, MBA on Cannabinoids & Gastrointestinal Ailments
2023-04-05 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Adam Abodeely discuss his research on cannabinoids & gastrointestinal ailments.
Article:
The minor cannabinoids and their potential implications for conditions of the gastrointestinal system
Register

International Committee: Cannabis in Thailand by Dr. Shiksha Gallow
2023-03-30 08:30 - 09:30 (America/Los_Angeles)
Dr. Shiksha Gallow presents to the SCC International Committee an update on Medical Cannabis in Thailand. Join us on Thursday, March 30th to hear all of the need to know information on what is happening politically in the Thailand medical cannabis movement, and where clinicians’ rights to practice cannabis medicine stand.
This is a SCC Members Only event. Must log in to your SCC account to register.
Register

SCC and Csequence Journal Club Presents: CBD & the Brain with Jong Rho, MD
2023-03-15 09:00 - 17:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Jong Rho discuss his research on how “Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.”
Jong M. Rho, MD
Dr. Rho is a Professor of Neurosciences, Pediatrics and Pharmacology at the University of California, San Diego, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University, and an M.D. from the University of Cincinnati. Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital, the University of California at Irvine, the Barrow Neurological Institute (Phoenix), University of Arizona and Arizona State University, and most recently, the University of Calgary and the Alberta Children’s Hospital. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the U.S. National Institutes of Health, Canadian Institutes of Health Research, Brain Canada, and a variety of intramural and extramural public and private sector sources.
Register

Quarterly Meeting: Featuring Igor Grant, MD, FRCP(C)
2023-02-17 09:00 - 10:00 (America/Los_Angeles)
Description
Igor Grant, M.D., F.R.C.P. (C)
Distinguished Professor, UC San Diego, Department of Psychiatry
Director, Center for Medicinal Cannabis Research
Dr. Igor Grant is Distinguished Professor and director of the HIV Neurobehavioral Research Program and the Center for Medicinal Cannabis Research at the University of California San Diego (UCSD). Dr. Grant served as Chair of the UCSD Department of Psychiatry from 2014-2019. He is a neuropsychiatrist who graduated from the University of British Columbia School of Medicine (1966), and received specialty training in psychiatry at the University of Pennsylvania (1967-1971), and additional training in neurology at the Institute of Neurology (Queen Square) (1980-1981), London, U.K. Dr. Grant’s academic interests focus on the effects of various diseases on brain and behavior, with an emphasis on translational studies in HIV, and drugs of abuse. He has contributed to approximately 800 scholarly publications and is principal investigator of several NIH studies.
Since 2000, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis.
Headquartered at the University of California San Diego (UCSD), the Center has completed several studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis, as well as cannabis and driving impairment. Results of the studies have been published in the scientific literature and are available at: http://www.cmcr.ucsd.edu/, many found evidence of at least short term benefit of medicinal cannabis.
Currently the CMCR is conducting a number of studies on both therapeutic potentials (e.g., with pain, autism, anxiety, metabolic syndrome, and diabetes) and potential risks (e.g., automobile driving) of medicinal cannabis. Studies are beginning to explore modes of administration and specific cannabinoids (e.g., THC, CBD).
CMCR has been the source of authoritative information that is developing on medicinal cannabis and has consulted with the Legislature of the State of California, the Office of the Lieutenant Governor of California (Blue Ribbon Commission’s Regulatory & Tax Structure Working Group), and contributed to the recent National Academies report, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” (2017).
Register

Natural Healing Hawaii - A naturopathic lifestyle EXPO
2023-02-04 09:00 - 2023-02-05 18:00 (America/Los_Angeles) | Blaisdell Exhibition Hall
The natural medicine focused expo is a great opportunity for healthcare professionals to collaborate together and discuss current issues, receive educational information, and dialogue on key issues like the Dual Use of Cannabis Task Force panel discussion which includes Ryan’s Law.
While there you can also buy some of the best medical cannabis books and informative material. Please bring strong shopping bags! Hope to see you there!
Register

Canna Talk: Pharmacy Edition -- Featuring Farzana Kennedy, RPh, BSPharm, FACA
2023-01-11 09:00 - 10:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on January 11th as we hear from our special guest Farzana Kennedy, RPh, BSPharm, FACA. Dr. Kennedy will discuss her background, how she became involved in cannabis medicine, and answer pertinent questions related to her course module on Cannabis and Policy: Impacts on the Healthcare Environment as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.”
This educational webinar series is free for all to attend.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Farzana Kennedy
Alan Ao
Bobby Vincent
Speaker bio:
Farzana Kennedy, RPh, BSPharm, FACA, is the owner, president, and director of clinical operations of NewLeaf, a West Virginia medical cannabis operator. She is a founding member and past president and pharmacist in charge of Dalitso LLC in Virginia where she managed all cultivation, processing, and dispensary functions.
As a founding board member and the inaugural president of the Virginia Medical Cannabis Coalition (VMCC) Farzana worked to establish and expand Virginia’s medical cannabis program by being involved in the regulatory and legislative process. She is also the chair of the Virginia Pharmacist Association (VPhA) Academy of Medical Cannabis and provides Virginia pharmacists with cannabis industry training and education.
Farzana has over twenty-five years of compounding and clinical pharmacy experience, most notably as the former owner and president of Alexandria Compounding Pharmacy. She is an appointee to the Northern Virginia Regional Human Rights Committee (NVRHRC) and is currently working with Virginia Department of Behavioral Health and Developmental Services as a COVID-19 clinical pharmacist consultant for the mental health and substance use disorder population.
Farzana received her pharmacy degree from Howard University School of Pharmacy. She is a 2023 MS candidate at the University of Maryland Baltimore Graduate School Medical Cannabis Science and Therapeutics program and is a member of several professional pharmacy and cannabis organizations.

Canna Talk: Pharmacy Edition -- Featuring Codi Peterson, PharmD, MS
2022-12-07 09:00 - 22:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on December 7th as we hear from our special guest Codi Peterson, PharmD, MS. Dr. Peterson will discuss his background, how he became involved in cannabis medicine, and give the insider view on the two courses he developed as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” This educational webinar series is free for all to attend.
Cannabis: A Rich History Clouded in Stigma
The journey of cannabis through the millennia is woven between stories of agriculture, medicine, spirituality, and recreation. The pathway to modern-day reformation requires an understanding of how political agendas shaped cannabis into the polarizing topic it is today. This course addresses cannabis prohibition and how the subsequent War on Drugs has disproportionately affected BIPOC communities. Course participants will learn how the stigmatization of cannabis and its consumption continues to exist today as a multifaceted issue.
The Future of Cannabis Medicine
The future of cannabis and cannabinoid-based medicine is riddled with competing interests and powerhouse industries. Prohibition has led to difficulties studying the cannabis plant on both a molecular level as well as large scale clinical trials. The endocannabinoidome is an expanded scope of what science currently knows and the questions that still need to be resolved as we move forward. The future implications of this knowledge are boundless and have the potential to significantly influence our approach to medical practices. Course participants will gain an understanding of the relationship between varying cannabinoid activity and the endocannabinoid system (ECS), become familiar with the expanded scope of the endocannabinoidome (eCBome), and much more.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers
Bobby Vincent
Alan Ao
Codi Peterson
Speaker bio:
Dr. Codi Peterson is a pediatric pharmacist and cannabis science expert. Leveraging a decade of clinical pharmacy experience, Codi strives to bridge the gap between healthcare and cannabis through education and advocacy. He is PharmD graduate from Duquesne University and later graduated with an MS in Medical Cannabis Science & Therapeutics. Codi is the Chief Science Officer of The Cannigma, a science forward media company who wants to help the world get cannabis. Dr. Peterson is also an educator for OCEMT where he teaches pharmacology to paramedics in southern California. Codi is co-founder of the Pharmacists Cannabis Coalition of California (PCCC), a public-benefit nonprofit dedicated to educating and elevating California pharmacists in the cannabis space. Additionally Codi is an advisor to numerous companies in the cannabis industry, including Hembel and the Cannabis Spa Association. He believes that cannabis is medicine and patients deserve access to medicine, which includes the right to speak with a healthcare professional.

Canna Talk: Pharmacy Edition -- Featuring Michael Ruggiero, PharmD, AAHIVP
2022-11-16 09:00 - 10:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on November 16th as we explore The Cannabis Pharmacist: A Bottom-up Clinical Approach with Michael Ruggiero, PharmD, AAHIVP. Dr. Ruggerio will discuss his background, how he became involved in cannabis medicine, and provide a glimpse into the material covered in his course. This course addresses the primary differences between the medical cannabis industry and traditional pharmaceuticals, teaches participants how to confidently develop tailor-made dosing protocols for patients, and how to comprehend the nuances of various dosage forms and ROAs for cannabinoid-based products, along with much more. If you are interested in taking the course beforehand so that you can ask your questions live, you can purchase the course here.
This educational webinar series is free for all to attend.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Alan Ao
Bobby Vincent
Michael Ruggiero
Speaker Bio:
Dr. Michael Ruggiero is the Regional Pharmacy Manager for Beyond / Hello in Pennsylvania. Prior to entering the Cannabis Industry he worked as a community pharmacist with certifications in medication therapy management, HIV, and cannabis. Since beginning to work in the industry he has given educational presentations on cannabis to healthcare and non-healthcare professionals alike, spoke on a podcast for Cannigma, provided Veteran driven education, created knowledge assessments for his team, developed oral product formulation dosing charts for the products at his dispensary, and currently is Vice President of International Society of Cannabis Pharmacists. In addition he teaches HIV pharmacotherapeutics to Physician Assistant students at Thomas Jefferson University.

Canna Talk: Pharmacy Edition -- Featuring Curriculum Co-Directors
2022-10-12 21:30 - 22:30 (America/Los_Angeles)
Don’t miss the kickoff event “Canna Talk: Pharmacy Edition” on October 12th as we explore the course material that is covered in the new curriculum: Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.
This educational webinar series is free for all to attend. The curriculum co-directors Alan Ao, PharmD and Bobby Vincent, III, PharmD, RPh will share a brief overview of what course participants can expect to learn after completing this curriculum and will also delve deeper into the specific topics that Dr. Alan Ao covers in his module The Cannabis Pharmacist: A Bottom-up Clinical Approach. Learn more in their bios below.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Alan Ao, PharmD, Bobby Vincent
Alan Ao, PharmD
Dr. Alan Ao is a registered pharmacist and lifelong NJ native. With over 20 years of retail experience, the majority of his professional career has been spent working alongside patients in independent retail settings specializing in patient care counseling, prescription drug compounding, and alternative medicine. Dr. Ao served as Vice President/Clinical Pharmacist in one of New Jersey’s first vertically integrated alternative treatment centers for 2.5 years before launching his own consulting firm. He’s the Founder and President of Plants and Prescriptions – a consulting firm developing an industry where cannabis and modern-day healthcare collide through education and advocacy. He currently serves as an advisory board member for the Association of Cannabis Health Equity and Medicine and pharmacy course director for the Society of Cannabis Clinicians. Dr. Ao is also involved as a course instructor for dispensary operations for both NJ Cannabis Certified and the Minority Cannabis Academy.
Bobby Vincent, III, PharmD, RPh
Bobby Vincent, III, PharmD, RPh is a Clinical Cannabinoid Pharmacotherapist born and raised in Richmond, Virginia. Dr. Vincent is driven by a passion to bridge the medical cannabis industry with communities in need. Dr. Vincent currently serves the northern Virginia and Washington, D.C. metropolitan area as a pharmacist and medical consult– providing care for hundreds of cannabis patients. Dr. Vincent is the founder of Cannabis Health Alliances, LLC., building partnerships to advance therapy, policy and patient accessibility. He also serves as the Communications Chair for the Virginia Pharmacists Association Academy of Medical Cannabis and a member of the organization’s Task Force for Racial Diversity, Equity, and Inclusion.
Dr. Vincent is a graduate of Hampton University where he obtained a Doctor of Pharmacy degree. He recently earned his Masters of Cannabis Science and Therapeutics Degree at the University of Maryland, Baltimore – the first degree of its kind available in the United States. He has experienced a host of unique learning opportunities, including time abroad in Thailand, United Arab Emirates, and the Philippines as a medical volunteer. Dr. Vincent also spent time with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications as a pharmacy intern.
To join as a listener, enter code 856348569
Register to Attend

Monthly Journal Club – Dr. Thomas Marcotte, The Complex Relationship Between Cannabis and Driving
2022-10-07 09:00 - 10:00 (America/Los_Angeles)
Speaker:
Thomas Marcotte, PhD
Article:
Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial
Meet Dr. Thomas Marcotte:
Dr. Thomas Marcotte is Professor of Psychiatry at the University of California, San Diego, and Co-Director of the Center for Medicinal Cannabis Research, which has conducted clinical trials of cannabis for over 20 years and has an active, ongoing portfolio exploring the effects of cannabinoids (plant-based, synthetic) in various medical/psychiatric conditions. He is the principal investigator on studies addressing the effects that cannabis has on driving performance, including in combination with alcohol, as well as methods for detecting cannabis-related driving impairment. He is currently a principal investigator on a study examining cannabis for the treatment of sports-related injuries in elite athletes, and previously was the principal investigator on an NIH-funded take-home study of cannabis for the treatment of pain, and a co-investigator on cannabis studies addressing pain, as well spasticity in multiple sclerosis. Dr. Marcotte has served on the editorial boards of Neuropsychology and the Journal of the International Neuropsychological Society, was co-chair of the Research, Data and Technology subcommittee of the State of California Impaired Driving Task Force, and a member on the California Office on Traffic Safety Impaired Driving Blueprint Roundtable. He is co-editor of the book Neuropsychology of Everyday Functioning, 2nd Edition (Marcotte, Schmitter-Edgecombe & Grant)
Register to Attend

Monthly Journal Club - Dr. Ran Abuhasira, Cannabis is associated with Blood Pressure Reduction in Older Adults
2022-09-07 09:00 - 10:00 (America/Los_Angeles) | Society of Cannabis Clinicians
September 7, 2022
Speaker:
Ran Abuhasira, MD PhD,
Article:
Cannabis is Associated with Blood Pressure Reduction in Older Adults: A 24-hour ambulatory blood pressure monitoring study
Meet Dr. Ran Abuhasira
Department of Internal Medicine B, Rabin Medical Center, Beilinson Campus.
Dr. Abuhasira completed his PhD at the Cannabis Clinical Research Institute (CCRI) under the supervision of Prof. Victor Novack. The CCRI is part of the Clinical Research Center at Soroka University Medical Center in Beer-Sheva, Israel. His study focused on assessing the safety and efficacy of medical cannabis in the elderly population. His work was published in a number of papers and presented in scientific conferences worldwide.
Register to Attend

First International Congress on Medical Use of Cannabis and Entheogens
2022-09-02 08:00 - 2022-09-03 17:00 (America/Los_Angeles) | Lima, Peru
Tuesday, September 2, 2022 – Wednesday, September 3, 2022
Event Description
An academic conference with a clear objective, to bring together cannabis and entheogen experts to present scientific evidence and experience from their role in science and society; following the principles of ethics, empathy and with the human vision of medicine, for Peru and the world.

CSequence & The Society of Cannabis Clinicians Presents Journal Club: Cannabis vs. Opioids For Back Pain- Two New Studies
2022-07-01 09:00 - 10:30 (America/Los_Angeles) | Society of Cannabis Clinicians
The Society of Cannabis Clinicians Journal Club Featuring Dr. Dustin Sulak
Friday, July 1, 2022
Event Description

Join us for the upcoming SCC Journal Club featuring Dr. Dustin Sulak as he shares his presentation on “Cannabis vs. Opioids For Back Pain: Two New Studies!”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC members, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Meet Dr. Dustin Sulak:
Dr. Dustin Sulak
Dustin Sulak, D.O. is an osteopathic physician, licensed in Maine as a general practitioner. He is an expert in integrative medicine, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine, spirituality in healthcare, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy, a clinical hypnotherapist, Reiki sensei, practitioner of chi kung and yoga, and has studied with numerous conventional and alternative healers and physicians.
Dr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children. He received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency. Dr. Sulak is the founder of Integr8 Health and Healer.com, a medical cannabis education resource. He is a passionate teacher of clinicians, patients and industry professionals, and sits on the board of directors of two nonprofits focused on cannabis education, The Society of Cannabis Clinicians and Patients Out of Time.

Register to Attend

The SCC Quarterly Meeting: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics
2022-06-24 09:00 - 10:30 (America/Los_Angeles) | Society of Cannabis Clinicians
The Society of Cannabis Clinicians Quarterly Meeting Featuring Dr. Dustin Sulak
Friday, June 24, 2022
Event Description

Join us for the upcoming SCC Quarterly Meeting featuring Dr. Dustin Sulak as he shares his presentation on “Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics!”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Meet Dr. Dustin Sulak:
Dr. Dustin Sulak
Dustin Sulak, D.O. is an osteopathic physician, licensed in Maine as a general practitioner. He is an expert in integrative medicine, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine, spirituality in healthcare, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy, a clinical hypnotherapist, Reiki sensei, practitioner of chi kung and yoga, and has studied with numerous conventional and alternative healers and physicians.
Dr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children. He received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency. Dr. Sulak is the founder of Integr8 Health and Healer.com, a medical cannabis education resource. He is a passionate teacher of clinicians, patients and industry professionals, and sits on the board of directors of two nonprofits focused on cannabis education, The Society of Cannabis Clinicians and Patients Out of Time.

Register to Attend

Australian Medicinal Cannabis Symposium
2022-05-20 08:45 - 2022-05-22 15:00 (Australia/Sydney)
The United in Compassion Australian Medicinal Cannabis Symposium began as a patient led movement that changed the law and inspired a new industry for the benefit of Australian patients. Their focus remains on patients and helping them with better access by providing better education of the health workforce and promoting development of a viable, professional and patient focused industry.
Patients, clinicians, researchers and industry come together to examine exciting developments and to hear from renowned experts from home and from around the globe.

MORE INFO >>

SCC & CSequence Presents Journal Club: "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!"
2022-05-06 09:00 - 09:30 (America/Los_Angeles) | Society of Cannabis Clinicians
Friday, May 6, 2022 at 9am PDT / 12pm EDT
Research Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!”
Speaker: Dr. Mihkail Kogan
Moderator: Zach Moore, PhD
Event registration link:
https://cannabisclinicians.tradewing.com/event/YsyEfdp5favrgo2r7
Join us for an educational discussion with Mikhail Kogan, MD as he highlights his recent research article “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.”
Learn More About Mikhail Kogan:

Dr. Mikhail Kogan, MD is a Medical Director, GW Center for Integrative Medicine, and the Assistant Professor, George Washington University School of Medicine and Health Sciences.
He is an Integrative Medicine Fellowship Director, Primary Care Internal Medicine, Integrative Geriatrics, Functional Medicine, Integrative Palliative Care Physician.
He is also the founder and Executive Director of ex-officio, of AIM Health Institute, a 501 (c) (3) non-profit organization
Dr. Kogan is a founding Board Member of the American Board of Integrative Medicine, and a Board Member of the Art of Healing Foundation.
Dr Kogan is a leader in the newly-established field of Integrative Geriatrics. He is the chief editor of the first definitive textbook of the field entitled “Integrative Geriatric Medicine ”, published by Oxford University Press as part of Andrew Weil Integrative Medicine Library series and is frequent speaker at a variety of international conferences on the topics of Integrative Medicine and Geriatrics, healthy aging, and geriatrics, as well as neurodegenerative diseases, and use of medical cannabis. Additionally, he has published in both Integrative and Geriatric topics in leading US-based journals.
Dr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatrics Fellowship Program. He is the founder and director othe George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine, as well as serving as part-time faculty member of the George Washington Institute for Spirituality and Health, and the GW Center for Aging, Health and Humanities.
In addition to his academic roles at George Washington University Dr. Kogan serves on a number of national boards and organizations including: the American Board of Integrative Medicine within the American Board of Physician Subspecialists (ABPS), ProCure Art, PlantMed, and others. Dr Kogan is also the founder and the chair of the board of AIM Health Institute, a 501(c)(3) non-profit organization in the Washington, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay.
For Dr. Mikhail Kogan, the practice of medicine, much like the rest of his life, has been a journey spanning many miles and many cultures, with valuable new learning and different perspectives accruing from each stage along the way. Those many experiences – here and abroad, in the classroom and the clinic, professionally and personally – have given Dr. Kogan the skills, , openness, and inquisitiveness that set him apart, and distinguish him as a committed and caring practitioner within integrative medicine.
Born in Moscow, in the former Soviet Union, Dr. Kogan emigrated with his family in his teens, first to Israel,and then to the United States, where he obtained his medical degree from the Drexel University College of Medicine in Philadelphia, Pennsylvania. He followed a Primary Care and Social Medicine Track residency in Internal Medicine at Montefiore Medical Center in New York City, and a fellowship in Geriatric Medicine at the George Washington University Medical Center in Washington, D.C., which led to a position as an assistant professor of medicine in the Division of Geriatrics and Palliative Care.
In addition to his training in conventional Western medicine, Dr. Kogan has actively pursued a number of other healing arts and practices that have shaped his understanding of and approach to patient care. He is a graduate of a two-year training course in craniosacral therapy–a subtle osteopathic modality that has a wide range of effectiveness for different conditions such as headaches, back pains, and fatigue. He has also completed a four-year program at the Suluk Academy, a teaching center based on the principles and traditions of Sufism, where he learned how to incorporate meditation, mindfulness, and different spiritual practices into his daily life and his work with the patients. Among his many other areas of study are courses in Nutrition, therapeutic use of vitamins, Functional Medicine, botanicals, and other alternative modalities.
Weaving those tools into the fabric of his medical practice has enabled Dr. Kogan to provide innovative and effective treatments to his patients with minimal use of invasive procedures or heavy reliance on medications and to understand the importance of self-exploration, awareness and positive lifestyle changes as essential milestones on his patients’ journeys towards better health. Dr. Kogan is dedicated to helping patients with Alzheimer’s disease identify and correct underlying metabolic drivers work, which is primarily based on Dr. Dale Bredesen’s research and newly created ReCode protocol.
Dr. Kogan practices Geriatric and Integrative Medicine in a variety of settings: at the George Washington Hospital, at the GW Center for Integrative medicine, as well as serving patients in home visits.
Register to Attend

SCC & CSequence Journal Club Presents: "State Medical Cannabis Programs: What Physicians Should Know And Consider" Hosted By Richard Cheng, JD, CHC
2022-04-15 11:00 - 12:30 (America/Los_Angeles) | Society of Cannabis Clinicians
Friday, April 15, 2022 at 11am PDT / 2pm EDT

Research Presentation: “State Medical Cannabis Programs: What Physicians Should Know And Consider”

Speaker: Richard Cheng, JD, CHC
Moderator: Zach Moore, PhD

Event registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed
Join us for a robust discussion with Richard Cheng, JD, CHC, as we learn more about “State Cannabis Laws.”

Learn More About Richard Cheng:
Richard Cheng, JD, CHC
Richard Cheng is a healthcare and cannabis regulatory and corporate attorney, specializing in representing healthcare providers and cannabis businesses. He is also a healthcare professional holding a degree in Occupational Therapy (BSOT).

Register to Attend

SCC Quarterly Meeting: Dr. Lauren Streicher, "The Use of Cannabinoids in Menopause"
2022-04-08 09:00 (America/Los_Angeles) | Society of Cannabis Clinicians
Event Description

Join us for the upcoming SCC Quarterly Meeting featuring Dr. Lauren Streicher as she shares her presentation on “The Use of Cannabinoids in Menopause.”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Learn More About This Event:
There are over 60 million menopause women in the United States, and over 80% of those women experience debilitating and life shortening symptoms such as hot flashes and insomnia. Only 7% get a prescription to relieve those symptoms since there is a persistent (and false) perception that estrogen is dangerous. Many post menopause women are turning to cannabis. Dr. Lauren Streicher, a clinical professor of Obstetrics and Gynecology at the Feinberg School of Medicine, Northwestern University, and the Medical Director of the Northwestern Medicine Program for Menopause will discuss the potential role of cannabinoids in menopausal women.
Meet Dr. Lauren Streicher:

Lauren Streicher, MD is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine, and the medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society, a member of the Sexual Medicine Society of North America, Inc., The International Society for the Study of Women’s Sexual Health, and The Scientific Network on Female Sexual Health and Cancer. In addition to authoring multiple scientific publications, she has written multiple consumer books. Her most recent releases are Slip Sliding Away: Turning Back the Clock on Your Vagina and Hot Flash Hell: A Gynecologist’s Guide to Turning Down the Heat.
Dr. Streicher is the medical correspondent for Chicago’s top-rated news program, the WGN Morning News, and has appeared multiple times on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBC Nightly News, 20/20, and World News Tonight. She lives in Chicago with her writer-producer husband, Jason Brett, and their dog, KJ.

Register to Attend

CannX-Tel Aviv
2022-03-14 - 2022-03-15 | Tel Aviv, Israel
CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists, clinicians, entrepreneurs, investors, policymakers, and thought leaders for the ultimate opportunity to make an impact in the field. We haven’t had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel’s most cosmopolitan and vibrant city – Tel Aviv.

Monthly Journal Club: Bonni Goldstein, MD & Itzhak Kurek, PhD - Cannabis-Responsive Biomarkers & Autism Spectrum Disorder
2022-03-04 09:00 (America/Los_Angeles)
March 4, 2022 at 9am PST / 12pm EST

Article: Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.

Speakers: Bonni Goldstein, MD & Itzhak Kurek, PhD
Moderator: Zach Moore, PhD

Event registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed
Join us for a robust discussion with Bonni Goldstein, MD & Itzhak Kurek, PhD moderated by Zach Moore, PhD as we discover their newest publication, “Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.”
Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions that impact behavior, communication, social interaction, and learning abilities. Treatment of ASD with medical cannabis (MC) shows promising results in reducing the severity of certain behavioral aspects. The goals of this observational study are to demonstrate the potential of metabolic biomarkers to (1) objectively determine the impact on metabolites of MC treatment and (2) suggest the metabolic pathways of children with ASD, who respond to MC treatment.

Learn More About Dr. Bonni Goldstein:
Dr. Bonni Goldstein
Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. She completed her internship and residency at Children’s Hospital Los Angeles, where she also served as chief resident. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Over the last 13 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics. She has a special interest in treating children with intractable epilepsy, autism, cancer and other conditions. Her latest book, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little, Brown Spark. Dr. Goldstein recently co-authored a peer-reviewed article researching the use of Cannabis-Responsive biomarkers to document cannabis treatment efficacy, guide clinical decision-making and improve outcomes.

Learn More About Itzhak Kurek, PhD:
Itzhak Kurek, PhD
Itzhak Kurek, PhD is the co-founder and CEO of Cannformatics, Inc. a San Francisco-based biotechnology startup developing saliva-based Cannabis-Responsive™ biomarkers as a universal tool for the objective measurement of the physiological impact of any cannabinoid-based treatment. He has executive and research management experience in the Ag-Biotech, Nutritional Supplements and Biobased Products businesses. Previously he held positions at Solix Algredients, Kiverdi, Pioneer Hi-Bred (DuPont) and Maxygen. He has published over 70 peer-reviewed scientific papers and patents. Dr. Kurek received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California, Davis. Dr. Kurek has also conducted research at the Technical University of Munich, John Innes Center Norwich, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories.

REGISTER TO ATTEND

Cannabis Science & Industry Congress
2022-01-27 - 2022-01-29 | Parque Viva Main Gate, Alajuela, Costa Rica
January 27-29, 2022 | San Jose, Costa Rica
The Cannabis Congress has partnered with the Society of Cannabis Clinicians to develop the Medical Track of the event featuring clinicians and researchers presenting the latest research and clinical findings on the therapeutic applications of cannabis. Doctors from Latin America, the United States, the EU, and Canada will be addressing an array of the most sought-after clinical topics from pain, sleep, epilepsy, mental health and more, to clinician activism, historical perspectives and indigenous knowledge of cannabis medicine.

MORE INFO >>

Monthly Journal Club: Dr. Josh Kaplan on CBD Exposure and Behavioral Changes in Mice
2022-01-13 09:00 - 10:00 (America/Los_Angeles) | Zoom
9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK
The SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Josh Kaplan discuss a paper on adolescent CBD exposure in mice not having substantive negative impacts on a range of behaviors in adulthood. It may also improve the rate of learning under certain conditions.
Presenter:
Dr. Josh Kaplan
Article to be Discussed:

Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory

FREE for SCC members. $10 for non members.
Want to sign up to present an article? Contact us here.
Learn more about SCC membership options.

REGISTRATION >>

Dr. Josh Kaplan Josh Kaplan earned his Ph.D. in Behavioral Neuroscience in 2015 from Oregon Health & Science University and then joined the University of Washington for two postdoctoral fellowships where he trained in cannabinoid pharmacology. His work has contributed towards our understanding of the therapeutic potential of phytocannabinoids and the body’s endocannabinoid system. Dr. Kaplan’s research was instrumental in demonstrating the effectiveness of cannabidiol (CBD) as a monotherapy in treating medically-refractory seizures and improving autism-like social interaction deficits using pre-clinical genetic models of disease. Further, he utilized his expertise in electrophysiology and pharmacological techniques to demonstrate a significant non-endocannabinoid mechanism-of-action by which CBD achieves its therapeutic relevance. His later studies focused on the therapeutic utility of enhancing endocannabinoid function and the relevant interactions with other inhibitory systems in the brain.
Dr. Kaplan is currently an Assistant Professor of Behavioral Neuroscience at Western Washington University in Bellingham, WA, where he trains undergraduate and graduate students in his cannabis research lab. By utilizing animal behavioral, molecular, pharmacological, and electrophysiological techniques, the Kaplan lab is working to identify ways of improving the plant’s therapeutic benefits and safety across a range of conditions. Their aim is to identify optimized cannabinoid and terpene compositions that extend the therapeutic dosing range while bolstering efficacy and limiting adverse effects.
Beyond the lab, Dr. Kaplan is a devoted mentor, educator, and science communicator. He has contributed numerous articles to peer reviewed journals, book chapters, as well as written for websites and magazines including High Times, Cannabis and Tech Today, and Leafly. He’s also spoken internationally on cannabis science for all types of audience and consulted for documentaries and popular science books. He was included in High Times’ 100 Most Influential People in Cannabis in 2018.

Cannabis & Psychedelics Webinar
2021-12-16 09:00 - 10:30 (America/Los_Angeles)
Join us for the inaugural Cannabis & Psychedelics Webinar put on by the Society of Cannabis Clinicians is co-hosting with the Psychedelic Medicine Association.
The event will focus on highlighting the psychedelic effects of cannabis and the therapeutic approaches of how cannabis can be used in conjunction with psychedelics (for example, in between psychedelic-assisted therapy sessions to prolong the therapeutic benefits or within sessions to enhance effects, etc.). The webinar will also focus on research on how psychedelics engage with the endocannabinoid system. The featured speakers will highlight their work in the field of psychedelic medicine to provide information on how clinicians can get training to utilize entheogens in their clinical practice.
Speakers & Topics:

Dustin Sulak, DO: Beyond the Crutch and the Tonic: Cannabis as a Teacher
Saj Razvi, LPC: Cannabis & the Autonomic Nervous System: A Preferential Pathway for Psychedelic Therapy
Rebecca Kronman, LCSW: Facing stigmas of medical cannabis and psychedelic-assisted therapies for clinicians and patients
Mark Braunstein, DO, ABPN: Psychiatric and medical considerations, cannabis dosing as part of ketamine protocols
Matthew Campeau, LPC: Preventing and working with psychedelic crises, thresholds and safety planning

Further info on each speaker can be found in their bio below.
Free for SCC members, $25 for non-members

RSVP >>

Dustin Sulak, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis, the author of the first foundational text on its clinical use, Handbook of Cannabis for Clinicians: Principles and Practice, and a co-founder of Healer.com, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis, and serves on the board of directors of The Society of Cannabis Clinicians.

Saj Razvi, LPC is the founder and Director of Education at Psychedelic Somatic Institute. He was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy. He is faculty at Mind Medicine Australia and formerly taught PTSD studies at the University of Denver. He is the primary developer of the Psychedelic Somatic Interactional Psychotherapy (PSIP) modality which is a next generation non-ordinary state psychotherapy that maximizes the relational and autonomic healing capacity of psychedelic medicine to treat complex, childhood developmental trauma. His primary focus is to train clinicians to provide legal, effective psychedelic treatment in their private practice settings utilizing readily accessible medicines such as cannabis and ketamine. Click here to view an actual psychedelic therapy session using PSIP and cannabis.

Rebecca Kronman, LCSW is a licensed therapist and founder of Plant Parenthood, a digital and in-person community of parents who use psychedelics. She is also an assisting trainer with Fluence, a company that trains healthcare practitioners in harm reduction informed psychedelic preparation and integration. At her private practice in Brooklyn, she works with clients using mindfulness, experiential techniques and ketamine assisted psychotherapy to address depression, anxiety and life transitions. She also helps clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress Reduction, Mindfulness for Clinicians, Psychedelics 101 & 102 and Beyond Experience Psychedelic Integration Workshop. Outside of work, she is a mother of two boys ages 5 and 7.

Mark Braunstein, DO, ABPN Matthew trained as a psychotherapist at Naropa University in Transpersonal Counseling Psychology. He has been an Independent Rater with the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2012, currently supporting Phase 3 MDMA Assisted Psychotherapy studies. Matthew has trained in Ketamine Assisted Psychotherapy with the Ketamine Training Center. He has worked with thousands of suicidal and high acuity clients and is passionate about harm reduction and prevention. Matthew has 12 years clinical experience with individuals with mild to chronic and severe mental illnesses and has a strong ability to remain grounded and support clients in dysregulation, crisis, psychosis, or altered states of consciousness. In addition to developing psychedelic psychotherapy protocols, he practices ketamine and cannabis-assisted psychotherapy.

Matthew Campeau, LPC “Dr. B,” is a whole health psychiatrist. He completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry in 1997. Shortly thereafter, he began exploring the use of psychoactive plant-based medicines in the treatment of various psychiatric conditions in both children and adults. With over 22 years of clinical experience, Dr. B has pioneered a new path in psychiatric care that integrates wilderness programming, exercise, diet, spirituality, and natural medicines. Dr. B is the medical director for multiple mental health clinics, including a groundbreaking psychedelic psychotherapy practice in Durango, Colorado. His plant-based dosing protocols have made him a sought-after medical consultant, advisor, and educator. With a focus on expanding access, awareness, research, and safety in the field of psychedelics, Dr. B champions innovative technology and telemedicine at his company Reconscious Medical. His mission is to create tailored solutions that empower patients to live full, happy, unencumbered lives.

SCC International Veterinary Alliance Webinar: Dosing & Administration
2021-12-08 09:00 - 10:30 (America/Los_Angeles)
9-10:30am PST / 11am-12:30pm CST / 12-1:30pm EST / 5-6:30pm BST
Join an international lineup of experts exploring how veterinarians approach the philosophy of dosing and the main considerations when creating a treatment plan for animal patients. The SCC International Veterinary Alliance Webinar is open to anyone interested in the applications of cannabis in veterinary practice.
Topic:
Cannabis Dosing and Administration Strategies in Veterinary Medicine
Speakers (bios below):

Santiago Acosta, DVM – (Colombia)
Rafael Ricardo Santisteban-Arenas, DVM (Colombia)
Erik Almeida, DVM (Brazil)
Trina Hazzah, DVM (USA)
Gary Richter, DVM (USA)
Conny Mosley, DVM (Canada)
Sarah Silcox, DVM (Canada)

Free for SCC members, $10 for non-members

RSVP >>

Trina Hazzah, DVM was born and raised in Washington DC. She attended Tuskegee University School of Veterinary Medicine where she earned her Doctor of Veterinary Medicine in 2006. She has also completed the requirements to be a Certified Veterinary Chinese Herbalist from the Chi Institute of Traditional Chinese Veterinary Medicine. Dr. Hazzah developed an interest in cannabis medicine during her quest for finding effective integrative approaches for veterinary cancer patients. She has spent the last half a decade reading through available literature, attending multiple cannabis conferences and symposiums, while also learning from cannabis physicians. She is is the president and co-founder of the Veterinary Cannabis Society, which is the first US-based non-profit, 501(c)(3) organization building awareness of cannabis as medicine for pets.

Dr. Gary Richter has been practicing veterinary medicine in the SF Bay Area since 1998. He is certified in acupuncture, chiropractic, and Western herbology. Dr. Richter’s practice focuses on the benefits of conventional and holistic treatment methods for the preventative and therapeutic care of pets as well as educating professionals and pet owners on the benefits of integrative care. Dr. Richter was named Holistic Veterinarian of the Year for 2019 by the American Holistic Veterinary Medical Association, is currently the President of the American College of Veterinary Botanical Medicine, and is a founding member of the Veterinary Cannabis Society.

Santiago Acosta Colmenares, DVM is the CEO of ENDOVET and the President of the Latin American Veterinary Medicine Association. He is currently a professor of medicinal cannabis at the National University of Colombia, University of Rosario, and University of Caldas. He is a member Society of Cannabis Clinicians (SCC) and Canadian Association of Veterinary Cannabinoid Medicine (CAVCM). He is also an advisor to the Colombian Agricultural Institute on issues related to medicinal cannabis in veterinary medicine. He is an international speaker on Medicinal Cannabis and entheogens in veterinary medicine and also designs cannabis-based products.

Dr. Sarah Silcox is a pioneer in the world of veterinary cannabis use and is one of the founding directors and the current President of the Canadian Association of Veterinary Cannabinoid Medicine. An OVC ‘97 grad, she is a small animal veterinarian with over 20 years of clinical experience. Dr. Silcox has been active in general, locum, and emergency practice, founded her region’s first integrative medicine practice, and is currently operating her region’s first veterinary practice dedicated solely to palliative, hospice, and end-of-life care for pets. A passionate advocate for the veterinary use of cannabis and cannabinoid medicine, her interest in the potential benefits of medical cannabis for pets reaches back several years. With changes in legislation that legalized cannabis in Canada, she is grateful to now be able to guide her clients on the responsible use of cannabis for treating their pets and has seen numerous patients that have benefited from the therapeutic effects of this amazing plant.

Dr. Erik Amazonas is an Associated Professor of Veterinary Medicine at the Federal University of Santa Catarina. Dr. Amazonas was the first to include classes of endocannabinology in a veterinary school in Brazil in 2018. Dr. Erik collaborates with several universities and non profit organizations in Brazil and worldwide and is a member of the Veterinary Cannabis Society.

Dr. Cornelia (Conny) Mosley is a boarded anesthesiologist working as a Veterinary Consultant in Orthopedic Health and Pain for Elanco Canada as well as providing care for chronic pain patients in her Integrative Veterinary Pain Clinic at VCA Canada, 404 Veterinary Emergency and Referral Hospital in Newmarket, north of Toronto. She has a strong interest in pain management, in particular in the integrative and collaborative approaches to pain relief. Conny is certified in veterinary acupuncture. Dr. Mosley is also the founding director and vice president of the Canadian Association of Veterinary Cannabinoid Medicine, an organization that helps understand, educate and collaborate in research in cannabinoid medicine and it’s role in veterinary medicine.

Rafael Ricardo Santisteban-Arenas, DVM is a DVM and MSc from Universidad de Caldas en Colombia. He is currently an Assistant Professor Institución Universitaria Visión de las Américas, Pereira and Medical Coordinator Veterinary Clinic Institución Universitaria Visión de las Américas, Pereira. He is also a Veterinary Advisor for Khiron Life Sciences Corp and Member of Red Cannabis Medicinal Veterinaria, Colombia. His research publications include chronic gastrointestinal conditions, cannabinoid therapy in small animals, infectious diseases and palliative care.

Navigating The Complexities of Autism & Cannabis: Facts vs. Myths
2021-11-18 15:00 - 16:30 (America/Los_Angeles)
3-4:30pm PST, 6-7:30pm EST
The SCC is hosting an event to highlight the complexities of autism and cannabis, while dispelling fact vs. myth among this clinical research topic.
This free event on Thursday, November 18th will serve as an educational resource for both clinicians and patients/caregivers as they explore the complexities and challenges associated with autism spectrum disorder and the use of medical cannabis. During the event, our panelists will be sharing their clinical research insight, while breaking down the facts versus myths surrounding ASD and medicinal cannabis. A Q&A session will also take place. Our speaker and panelist line up includes the following:
Featured Keynote Speaker– Patricia Frye, MD
Host: Sherry Yafai, MD
Moderator: Minchul An, PharmD
Panelists:

Bonni Goldstein, MD
Dustin Sulak, DO
Dr. Muhsinah Morris
Melani Kane, PharmD
Genesis A. Emery

REGISTER >>
